Over 3 years, SGLT2 inhibitors were safely associated with a nearly one third reduction in the risk for serious liver events.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/sglt2-inhibition-promising-patients-cirrhosis-and-diuretics-2025a1000nfa?src=rss
Author :
Publish date : 2025-09-04 11:24:00
Copyright for syndicated content belongs to the linked Source.
